Joseph Trautwein has more than sixteen years experience in complex civil litigation including twelve years of service with the U.S. Department of Justice. He was Assistant U.S. Attorney in the civil division of the Philadelphia office until 2010, focusing primarily on health care and defense contractor fraud. Trautwein continues to pursue corporate wrongdoing on behalf of consumers and the government.
- With the $2.2B Risperdal settlement, Sheller, P.C.'s representation of whistleblowers totals over $6.4 billion, with three of the top five pharmaceutical settlements in history 2009: Pfizer $2.3 b
- A Philadelphia jury awarded $2.5 million to a twenty year old man whose family claimed he developed female-like breasts (gynecomastia) from taking the antipsychotic drug Risperdal for five years from
- April 27, 2010: In the third record whistleblower settlement for Sheller, P.C. in fifteen months, the firm represented a whistleblower who brought forth knowledge of wrongdoing by AstraZeneca. Astr
- The Sheller whistleblower team announced a $58.9 milllion settlement with Shire Pharmaceuticals over off-label marketing of ADHD drugs Adderall and Vyvanse in September, 2014. Court documents d